Recent articles
HEXO: Time to Abandon Ship?
Bargain hunters should continue to avoid HEXO's stock.
Why HEXO Stock Is Collapsing Today
HEXO's preliminary revenue figures for its fiscal fourth quarter aren't sitting well with investors today.
Better Buy: OrganiGram Holdings vs. Aurora Cannabis
Which of these top pot stocks is the better buy right now?
Better Buy: Biogen vs. Gilead Sciences
Which of these two biotech titans is the better buy right now?
3 Cancer Treatment Stocks to Buy Right Now
These three beaten-down cancer stocks could prove to be amazing value plays.
Why BeiGene Stock Tumbled in September
A short-seller report weighed on the Chinese biotech's shares last month.
Why AbbVie's Stock Jumped in September
AbbVie's shares reversed course last month. Here's why.
Why Amicus Therapeutics Stock Folded in September
The competitive outlook for a key therapy is worrying investors.
Better Buy: Aurora Cannabis vs. Canopy Growth
Which of these pot titans is the better buy?
2 Best Cannabis Stocks to Buy in October
Aphria and Charlotte's Web Holdings are both outstanding long-term growth vehicles. Here's why.
2 Great Stocks You Can Buy on Sale
AbbVie and Amgen are two great stocks that are way too cheap right now.
3 Top Small-Cap Stocks to Buy in October
These small-cap healthcare stocks are definitely worth checking out this month.
Why Geron Stock Is Jumping Today
Geron announced an important regulatory win today.
2 Marijuana Stocks to Flat-Out Avoid in the Fourth Quarter
These two top pot stocks will probably continue to struggle in the fourth quarter.
Why Immunomedics Stock Is Sinking Today
The market isn't pleased with its latest clinical update.
2 Penny Marijuana Stocks to Buy in the 4th Quarter
These two penny marijuana stocks may be worth adding to your portfolio right now.
Better Buy: AbbVie vs. Eli Lilly
AbbVie and Eli Lilly have both stumbled this year. Which of these top pharma stocks is better positioned for a rebound?
Catalyst Pharmaceuticals: Nothing Has Changed
Here's why Catalyst's shareholder might want to simply shrug off yesterday's downturn.
Why Catalyst Pharmaceuticals Stock Is Tumbling Today
Catalyst's latest bout of volatility could be a great buying opportunity for risk-tolerant investors.
Here's Why Aurora Cannabis Doesn't Deserve a Top-Shelf Valuation
A bet on this Canadian marijuana company is a bet on the political future of the country south of its home market.